Immunomodulation of PMN-MDSCs in 4T1 Breast Tumors
Corresponding Organization :
Other organizations : École Pratique des Hautes Études, Université de Bourgogne, Université Paris Sciences et Lettres, Weill Cornell Medical College in Qatar, Centre Georges François Leclerc, Centre National de la Recherche Scientifique, Inserm
Variable analysis
- Treatment with NaCl (Ctrl)
- Treatment with doxorubicin
- Treatment with GTN
- Tumor growth
- Proliferation of T lymphocytes co-cultured with PMN-MDSCs
- Balb/C mice
- 4T1 breast tumor cells
- PMN-MDSCs isolated from tumor-bearing mice
- T lymphocytes isolated from naive mice
- T lymphocytes activated by anti-CD3/anti-CD28 beads
- T lymphocytes labeled with cell traceTM violet
- Negative control: PMN-MDSCs cultured alone
- Positive control: T lymphocytes activated by anti-CD3/anti-CD28 beads
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!